Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide

European Journal of Cancer

Volumn 41, Issue 18, 2005, Pages 2948-2957

  Tentori, Lucio ^a   Leonetti, Carlo ^b   Scarsella, Marco ^b   Muzi, Alessia ^a   Vergati, Matteo ^a   Forini, Olindo ^a   Lacal, Pedro Miguel ^c   Ruffini, Federica ^c   Gold, Barry ^d   Li, Weixing ^e   Zhang, Jie ^e   Graziani, Grazia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

(ADP ribose) polymers; Blood brain barrier; Brain tumours; Cancer; Metastasis; Poly(ADP ribose) glycohydrolase; Poly(ADP ribose) polymerase; Temozolomide

Indexed keywords

GLYCOSIDASE; GLYCOSIDASE INHIBITOR; GPI 16552; N BIS(3 PHENYLPROPYL) 9 OXOFLUORENE 2,7 DIAMIDE; POLY(ADENOSINE DIPHOSPHATE RIBOSE)GLYCOHYDROLASE; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER INVASION; CENTRAL NERVOUS SYSTEM TUMOR; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERABILITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LIFESPAN; LUNG METASTASIS; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DACARBAZINE; DRUG INTERACTIONS; FLUORENES; GLYCOSIDE HYDROLASES; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; SKIN NEOPLASMS;

EID: 28244465243     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.08.027     Document Type: Article

References (30)

1. J.C. Ame, C. Spenlehauer, and G. de Murcia The PARP superfamily Bioessays 26 2004 882 893
2. G. Graziani, F. Battaini, and J. Zhang PARP-1 inhibition to treat cancer, ischemia, inflammation Pharmacol Res 52 2005 1 4
3. L. Tentori, and G. Graziani Chemopotentiation by PARP inhibitors in cancer therapy Pharmacol Res 52 2005 25 33
4. L. Tentori, C. Leonetti, and M. Scarsella Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site Blood 99 2002 2241 2244
5. L. Tentori, C. Leonetti, and M. Scarsella Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the anti-tumor activity of temozolomide against intracranial melanoma, glioma, lymphoma Clin Cancer Res 9 2003 5370 5379
6. L. Tentori, C. Leonetti, and M. Scarsella Brain distribution and efficacy as chemosensitiser of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumours Int J Oncol 26 2005 415 422
7. S.J. Miknyoczki, S. Jones-Bolin, and S. Pritchard Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor Mol Cancer Ther 2 2003 371 382
8. C.R. Calabrese, R. Almassy, and S. Barton Anti-cancer chemosensitisation and radiosensitisation by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361 J Natl Cancer Inst 96 2004 56 67
9. R.G. Meyer, M.L. Meyer-Ficca, and E.L. Jacobson Human poly(ADP-ribose) glycohydrolase (PARG) gene and the common promoter sequence it shares with inner mitochondrial membrane translocase 23 (TIM23) Gene 314 2003 181 190
10. M.L. Meyer-Ficca, R.G. Meyer, and D.L. Coyle Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments Exp Cell Res 297 2004 521 532
11. L. Davidovich, M. Vodenicharov, and E.B. Affar Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism Exp Cell Res 268 2001 7 13
12. S. Ohashi, M. Kanai, and S. Hanai Subcellular localisation of poly(ADP-ribose) glycohydrolase in mammalian cells Biochem Biophys Res Commun 307 2003 915 921
13. P. Chang, M.K. Jacobson, and T.J. Mitchinson Poly(ADP-ribose) is required for spindle assembly and structure Nature 432 2004 645 649
14. W. Ying, M.B. Sevigny, and Y. Chen Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death Proc Natl Acad Sci USA 98 2001 12227 12232
15. U. Cortes, W.M. Tong, and D.L. Coyle Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice Mol Cell Biol 24 2004 7163 7178
16. D.W. Koh, A.M. Lawler, and M.F. Poitras Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality Proc Natl Acad Sci USA 101 2004 17699 17704
17. A. Burkle Physiology and pathophysiology of poly(ADP-ribosyl)ation Bioessays 23 2001 795 806
18. Z.P. Chen, J.B. Schell, and C.T. Ho Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts Cancer Lett 129 1998 173 179
19. G.Y. Yang, J. Liao, and K. Kim Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols Carcinogenesis 19 1998 611 616
20. S. Islam, N. Islam, and T. Kermode Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells Biochem Biophys Res Commun 270 2000 793 797
21. C. Keil, E. Petermann, and S.L. Oei Tannins elevate the level of poly(ADP-ribose) in HeLa cell extracts Arch Biochem Biophys 425 2004 115 121
22. X.C. Lu, E. Massuda, and Q. Lin Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat Brain Res 978 2003 99 103
23. S. Cuzzocrea, R. Di Paola, and E. Mazzon PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion FASEB J 19 2005 558 566
24. T. Genovese, R. Di Paola, and P. Catalano Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice Crit Care Med 32 2004 1365 1374
25. Y. Zhang, F.-X. Chen, and P. Mehta The design of groove and sequence selective alkylation of DNA by sulfonate esters tethered to lexitropsin Biochemistry 32 1993 7954 7965
26. L. Tentori, O. Forini, and E. Fossile N3-methyladenine induces early poly(ADP-ribosylation), reduction of nuclear factor-kappa B DNA binding ability, and nuclear up-regulation of telomerase activity Mol Pharmacol 67 2005 572 581
27. L. Tentori, A. Balduzzi, and I. Portarena Poly(ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester Cell Death Differ 8 2001 817 828
28. S. Cuzzocrea, M.C. McDonald, and E. Mazzon Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly(ADP-ribose) polymerase, in a rodent model of lung injury Biochem Pharmacol 63 2002 293 304
29. J. Falsig, S.H. Christiansen, and S. Feuerhahn Poly(ADP-ribose) glycohydrolase as a target for neuroprotective intervention: assessment of currently available pharmacological tools Eur J Pharmacol 497 2004 7 16
30. R. Alvarez-Gonzalez, T.A. Watkins, and P.K. Gill Regulatory mechanisms of poly(ADP-ribose) polymerase Mol Cell Biochem 193 1999 19 22